Alejandra Carvajal
2023
Compensation breakdown
Non-Equity Incentive Plan | $120,557 |
---|---|
Option Awards | $780,966 |
Salary | $430,560 |
Stock Awards | $274,148 |
Other | $7,000 |
Total | $1,613,231 |
Carvajal received $781K in option awards, accounting for 48% of the total pay in 2023.
Carvajal also received $120.6K in non-equity incentive plan, $430.6K in salary, $274.1K in stock awards and $7K in other compensation.
Rankings
In 2023, Alejandra Carvajal's compensation ranked 716th out of 2,878 executives tracked by ExecPay. In other words, Carvajal earned more than 75.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 716 | 75th |
Manufacturing | 414 | 74th |
Chemicals And Allied Products | 281 | 69th |
Drugs | 275 | 68th |
Pharmaceutical Preparations | 181 | 71st |
Carvajal's colleagues
We found six more compensation records of executives who worked with Alejandra Carvajal at Mersana Therapeutics in 2023.
2023
Anna Protopapas
Mersana Therapeutics
Chief Executive Officer
2023
Martin Huber
Mersana Therapeutics
Chief Executive Officer
2023
Arvin Yang
Mersana Therapeutics
Chief Medical Officer
2023
Brian DeSchuytner
Mersana Therapeutics
Chief Financial Officer
2023
Timothy Lowinger
Mersana Therapeutics
Senior Vice President, Chief Science and Technology Officer
2023
Mohan Bala
Mersana Therapeutics